In a previous study, we showed that CA9 is strongly expressed in about a third of NSCLC, and is correlated with angiogenic pathways and poor prognosis in operable disease.14 In this study, we provide evidence that CA9 is also involved in intratumoural immunosuppression pathways. This evidence concerns the gene CA9 and non-small cell lung carcinoma.